Respiree

Respiree is a leading medical device company dedicated to providing targeted predictions and diagnoses using advanced breath-cardio informatics. Respiree leverages state-of-the-art, clinically-validated AI to manage disease progression across the healthcare continuum. The Respiree platform utilizes data from Electronic Health Records (EHR) and its proprietary, US-patented, and FDA-cleared sensors to longitudinally measure and track disease progression.

With a focus on innovation and patient care, Respiree is expanding its reach across the globe. Respiree is available in the US and Asia-Pacific regions and has established commercial partnerships with global channel partners to scale its offerings. The company is committed to upholding the highest standards of quality and safety, demonstrated by its CE marking and regulatory clearances from the Therapeutic Goods Administration in Australia, as well as 510(k) clearance from the United States Food and Drug Administration (FDA).

Respiree continues to push the boundaries of medical technology, aiming to improve patient outcomes and transform healthcare delivery. We invite the manager of Respiree to create a customized and exclusive company showcase and product listing on our platform to further highlight their achievements and offerings.